ARTICLE | Company News
Chiron, MorphoSys GmbH deal
January 25, 1999 8:00 AM UTC
CHIR received a non-exclusive license to use MorphoSys' Human Combinatorial Antibody Library (HuCAL) in its cancer program. MorphoSys will receive license fees, milestones and royalties. ...